Project Grant R01GM170991
- The National Institute of General Medical Sciences awarded the University of New Mexico Health Sciences Center $419,375 on August 25, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop two artificial intelligence models—Protein2Hypothesis and ProteinChem2Hypothesis—that translate protein and chemical sequences into human-readable functional descriptions and mechanistic explanations of protein function. Project 1 will transform an existing Protein2Text...
- The National Institute of General Medical Sciences awarded the University of New Mexico $404,464 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop computational methods for characterizing nucleic acids and DNA nanotechnology toward therapeutic design. The research team at UNM will combine quantum chemistry, molecular dynamics, and machine learning to predict electronic structure properties—electron densities, energies, and forces—of...
- The National Institute of General Medical Sciences awarded the University of New Mexico $370,940 on August 22, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop high-throughput free energy computational methods for small molecule, peptide, and protein design in drug discovery and optimization. The project integrates enhanced sampling methods with multisite lambda dynamics (MSLD) to create MSLD++, a framework intended to overcome computational...
- The National Institute of General Medical Sciences awarded the University of New Mexico Health Sciences Center $354,041 on July 22, 2026, to support predoctoral training in transdisciplinary basic biomedical sciences under the Biomedical Research and Research Training program (CFDA 93.859). The award funds the Transdisciplinary Basic Biomedical Sciences T32 program, which provides stipends and training support to 14 predoctoral students (7 per year) during years 2 and 3 of PhD study within the...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $640,500 to the University of New Mexico Health Sciences Center for a two-year biomedical research project under the Biomedical Research and Research Training program (CFDA 93.859), with an award date of September 30, 2025, and completion date of September 29, 2027. The project focuses on elucidating the mechanisms of tubulin post-translational modifications (PTMs) and their regulation...
- Federal Grant Award Summary The University of New Mexico Health Sciences Center received a $2,094,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2029. This research project investigates the intersection between the methionine cycle and coronavirus RNA capping mechanisms, with the primary objective of identifying novel drug targets to inhibit...
- The National Institute of General Medical Sciences (NIGMS), through its Biomedical Research and Research Training program (CFDA 93.859), awarded a $355,584 Project Grant to the New Mexico Institute of Mining and Technology (New Mexico Tech) on August 18, 2023. This funding will support research to determine the biochemical basis and functional implications of the interaction between the proteins XRN2 and DDX23, and explore their cooperative role in regulating RNA-DNA hybrid structures...
- The National Institute of General Medical Sciences awarded the University of California, San Diego $507,265 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct design and mechanistic investigations of metalloenzymes and metalloproteins. The award funds research combining top-down study of natural metalloenzymes with bottom-up design of artificial ones. The primary focus is nitrogenase, the only known biological system capable of...
- The National Institute of General Medical Sciences awarded the University of New Mexico $2.358 million on August 15, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop nuclear magnetic resonance microscopy using diamond quantum sensors. The award funds research in Acosta's lab to advance microscale NMR spectroscopy by leveraging nitrogen-vacancy color centers in diamond as quantum sensors. NMR spectroscopy is widely used in chemistry, biology, and...
- The National Institute of General Medical Sciences, a bureau of the National Institutes of Health within the Department of Health and Human Services, awarded $301,936 to the University of California, Los Angeles on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859). The award funds data-science-guided study and design of phosphoranyl radical-mediated reactions for the discovery of novel pharmaceutical compounds. The research builds a comprehensive,...
The National Institute of General Medical Sciences awarded New Mexico Institute of Mining and Technology $148,495 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop and apply an AI-enabled measurement framework evaluating how place-based biomedical policies affect biomedical PhD careers, innovation, and firm-level dynamics. The project pursues three integrated aims. Aim 1 constructs a validated place-by-year database of U.S. state- and county-level biomedical policies, using a large language model-based agentic workflow with human-in-the-loop validation to extract policy instruments, eligibility rules, geographic scope, timing, and implementation intensity from legislative and administrative texts. Aim 2 links these policy measures to restricted-access longitudinal administrative microdata at federal statistical research data centers to estimate how biomedical policies affect biomedical PhD wages, employment stability, mobility, employer type, startup participation, and innovation outcomes. Aim 3 examines firm-level responses including firm entry, survival, employment, growth, and innovation, and assesses whether observed effects reflect net local gain or primarily reallocate firms and scientists across regions. The award is classified as a Project Grant and supports the principal investigator's long-term goal of providing evidence that informs public investments designed to strengthen the biomedical research workforce and innovation ecosystem. Performance occurs in Socorro, New Mexico, with a period of performance ending May 31, 2029.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $148.5k | 8/26/26 |